Investigating Safety and Pharmacokinetics of 2 Different Single Doses of NNC128-0000-2011 in Haemophilia A or B Patients
Status:
Completed
Trial end date:
2011-07-01
Target enrollment:
Participant gender:
Summary
This trial is conducted in Europe and Japan. The aim of this trial is to assess the safety
and pharmacokinetics (the rate at which the body eliminates the trial drug) of single doses
of NNC128-0000-2011, when administered i.v. (intravenously) to haemophilia patients.